Showing 921 - 940 results of 101,811 for search '(( 5 c decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.72s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924
  5. 925
  6. 926
  7. 927
  8. 928
  9. 929

    mGluR5 binding potential (BP<sub>ND</sub>) decreased in epilepsy models according to time periods after status epilepticus. by Hongyoon Choi (541919)

    Published 2014
    “…<p>(AC) BP<sub>ND</sub> decreased globally in acute period after status epilepticus. …”
  10. 930

    Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study by Kelly Fellows Maxwell (6852752)

    Published 2019
    “…</p><p>Results</p><p>FSS scores decreased from a baseline of 5.51 (95% CI: 4.86, 6.16) to a mean of 3.03 (95% CI: 2.23, 3.82) at 12 months (p < 0.001). …”
  11. 931
  12. 932
  13. 933
  14. 934

    GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

    Published 2021
    “…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
  15. 935

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…<p>(A-B) GCase, (C-D) gluocosylceramide (GlcCer), and (E-F) glucosylsphingosine (GlcSph) levels measured in whole brain homogenate and liver homogenate of C57Bl/6 wild type (WT) and <i>GBA1</i> D409V KI heterozygous (HET) mice at 5 months of age (n = 10/age). …”
  16. 936
  17. 937
  18. 938
  19. 939

    Fig 5 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
  20. 940